Insight 2811 Inc’s MiMedx Group MDXG Stock Holding History

Insight 2811 Inc’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,032	Closed	-$119K	–	90
2023 Q2	$119K	Hold	18,032	–	–	0.06%	95
2023 Q1	$61.5K	Hold	18,032	–	–	0.04%	91
2022 Q4	$50K	Buy	+18,032	New	+$53.9K	0.03%	95

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Insight 2811 Inc's MDXG Position: Q3 2023 in Review

Insight 2811 Inc sold out of MiMedx Group (MDXG) in Q3 2023, closing a stake of 18,032 shares — an estimated $119K sold.

Insight 2811 Inc first reported a position in MDXG in Q4 2022 and held it in 3 quarters. The position peaked at $119K in Q2 2023. 185 funds tracked by Wall St. Rank hold MDXG as of Q3 2023.

Insight 2811 Inc reported no remaining MiMedx Group position as of Q3 2023 after selling out during the quarter.
Insight 2811 Inc sold 18,032 MiMedx Group shares in Q3 2023, an estimated $119K.
Insight 2811 Inc first reported a position in MiMedx Group in Q4 2022 and held it in 3 quarters.
Insight 2811 Inc's MiMedx Group position peaked at $119K in Q2 2023.
185 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2023.

Based on Insight 2811 Inc's 13F filing for Q3 2023, filed 14 Nov 2023.